2李福海 相开宇 陈曼玲.正常人及胃癌绒毛膜促性腺激素及其受体的比较研究[J].Chinese Journal of Cancer Research（中国癌症研究：英文版）,1993,4:55-57.
3Thompson W J, Brooker G, Appleman MM. Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. MethodsEnzymol, 1974,38:205-212.
4ChV Rao. The beginning of a new era in reproductive biology andmedicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol, 1996,4:41-53.
5Gudermann T, Birnbaumer M, Birnbaumer L. Evidence for dualcoupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2 + mobilization. J BiolChem, 1992,267: 4479-4488.
6Faure M, Voyno-Yasenetskaya TA, Bourne HR. cAMP and βγsubunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 ceils. J Biol Chem, 1994,269:7851-7854.
7Cameron MR, Foster JS, Bukovsky A, et al. Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine5'-monophosphates in porcine granulosa cells. Biol Reprod, 1996,55:111-119.
8Selbie LA, Hill SJ. G protein-coupled receptor cross-talk: the finetuning of multiple receptor signalling pathways. Trends PharmacolSci, 1998,19: 87-93.
9Schneider T, Igelmund P, Hescheler J, et al. G protein interactionwith K+ and Ca2+ channels. Trends Pharmacol Sci, 1997, 18: 8-11.
10Gillott DJ, Iies RK, Chard T. The effects of β human chorionicgonadotrophin on the in vitro growth of bladder cancer cell lines. BrJ Cancer, 1996,73: 323-326.
